The increasing prevalence of listeriosis-what are we missing?

QJM: An International Journal of Medicine

Volumn 103, Issue 7, 2009, Pages 519-522

  Khatamzas, E ^a   Hughes, H ^a   Grant, K A ^b   McLauchlin, J ^c   Bowler, I C J W ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c National Infections Surveillance Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMOXICILLIN; INFLIXIMAB; LEFLUNOMIDE; MEROPENEM; METHOTREXATE; PREDNISOLONE;

ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; INFECTION RISK; LISTERIOSIS; MALE; PRIORITY JOURNAL;

EID: 77954269918     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcp181     Document Type: Article

References (11)

1. Farber JM, Peterkin PI. Listeria monocytogenes, a food-borne pathogen. Microbiol Rev 1991; 55:476-511.
2. Gillespie IA, McLauchlin J, Grant KA, Little CL, Mithani V, Penman C, et al. Changing pattern of human listeriosis, England and Wales, 2001-2004. Emerg Infect Dis 2006; 12:1361-6.
3. Denny J, McLauchlin J. Human Listeria monocytogenes infections in Europe-an opportunity for improved European surveillance. Euro Surveill 2008; 13:pii8082.
4. Goulet V, Hedberg C, Le Monnier A, de Valk H. Increasing incidence of listeriosis in France and other European countries. Emerg Infect Dis 2008; 14:734-40.
5. Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP. Rates of serious infection, including sitespecific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2006; 54:2368-76.
6. Zink A, Askling J, Dixon WG, Klareskog L, Silman AJ, Symmons DP. European Biologics Registers - methodology, selected results, and perspectives. Ann Rheum Dis 2009; 68:1240-6.
7. Dinarello CA. Anti-cytokine therapeutics and infections. Vaccine 2003; 21(Suppl. 2):S24-34.
8. Kroesen S, Widmer AF, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford) 2003; 42:617-21.
9. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295:2275-85.
10. Bowie VL, Snella KA, Gopalachar AS, Bharadwaj P. Listeria meningitis associated with infliximab. Ann Pharmacother 2004; 38:58-61.
11. Department of Health and Food Standards Agency. Listeria - Keeping Food Safe. 2008. Copyright: Crown.